| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 GBDD Collaborators Lancet 15 (402), 203-234, 2023 | 1753* | 2023 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 412 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 390 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 377 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 258 | 2024 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 173 | 2024 |
| A branched-chain amino acid-related metabolic signature characterizes obese adolescents with non-alcoholic fatty liver disease M Goffredo, N Santoro, D Tricò, C Giannini, E D’Adamo, H Zhao, G Peng, ... Nutrients 9 (7), 642, 2017 | 127 | 2017 |
| Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents D Tricò, A Natali, S Arslanian, A Mari, E Ferrannini JCI insight 3 (24), 2018 | 122 | 2018 |
| Evaluation of the incidence and potential mechanisms of tracheal complications in patients with COVID-19 G Fiacchini, D Tricò, A Ribechini, F Forfori, E Brogi, M Lucchi, S Berrettini, ... JAMA Otolaryngology–Head & Neck Surgery 147 (1), 70-76, 2021 | 105 | 2021 |
| Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug L Nesti, D Tricò, A Mengozzi, A Natali Cardiovascular Diabetology 20 (1), 109, 2021 | 95 | 2021 |
| Metabolic features of nonalcoholic fatty liver (NAFL) in obese adolescents: findings from a multiethnic cohort D Tricò, S Caprio, G Rosaria Umano, B Pierpont, J Nouws, A Galderisi, ... Hepatology 68 (4), 1376-1390, 2018 | 86 | 2018 |
| Elevated α-Hydroxybutyrate and Branched-Chain Amino Acid Levels Predict Deterioration of Glycemic Control in Adolescents D Tricò, H Prinsen, C Giannini, R De Graaf, C Juchem, F Li, S Caprio, ... The Journal of Clinical Endocrinology & Metabolism 102 (7), 2473-2481, 2017 | 80 | 2017 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 63 | 2024 |
| Protein and amino acids in nonalcoholic fatty liver disease D Tricò, E Biancalana, A Solini Current Opinion in Clinical Nutrition & Metabolic Care 24 (1), 96-101, 2021 | 62 | 2021 |
| Mechanisms through which a small protein and lipid preload improves glucose tolerance D Tricò, S Baldi, A Tulipani, S Frascerra, MP Macedo, A Mari, E Ferrannini, ... Diabetologia 58, 2503-2512, 2015 | 59 | 2015 |
| Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis D Tricò, A Mengozzi, L Nesti, M Hatunic, R Gabriel Sanchez, T Konrad, ... Diabetologia 63, 206-218, 2020 | 55 | 2020 |
| Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence A Natali, L Nesti, D Tricò, E Ferrannini Cardiovascular Diabetology 20 (1), 196, 2021 | 53 | 2021 |
| Effects of low-carbohydrate versus mediterranean diets on weight loss, glucose metabolism, insulin kinetics and β-cell function in morbidly obese individuals D Tricò, D Moriconi, R Berta, S Baldi, A Quinones-Galvan, L Guiducci, ... Nutrients 13 (4), 1345, 2021 | 53 | 2021 |
| Lower insulin clearance parallels a reduced insulin sensitivity in obese youths and is associated with a decline in β-cell function over time A Galderisi, D Polidori, R Weiss, C Giannini, B Pierpont, D Tricò, S Caprio Diabetes 68 (11), 2074-2084, 2019 | 52 | 2019 |
| Manipulating the sequence of food ingestion improves glycemic control in type 2 diabetic patients under free-living conditions D Tricò, E Filice, S Trifirò, A Natali Nutrition & diabetes 6 (8), e226-e226, 2016 | 52 | 2016 |
Andrea NataliUniversity of PisaVerified email at med.unipi.it